Puja rituals are an integral part of Hindu culture. In order to stand out from numerous startups, currently competing with each other in the spiritual market domain, and to cater to millions of Hindus worldwide, WheresMyPandit has entered the field of mobile-commerce with the launch of its mobile application.
Built for Android users, WheresMyPandit expects an increase by three times for both inquiries and sales after the launch of the application. And, post the launch of the iOS application near to the Diwali season, it will multiply by nearly five times.
Not only can you book a pandit with a simple click through the application, but in the future, you can also chat or talk to the pandit to help you with various intricacies such as Muhurat timings and information about the puja on a real-time basis. A real-time tracking of the panditji will also be made available so you don't miss out on your muhurat timings while the pandit is on his way to conduct the puja.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7650651-mobile-commerce-with-wheresmypandit/
Bringing developers advanced integration, scalability and peripherals all in one chip, Texas Instruments (TI) (NASDAQ: TXN) today announced the Sitara™ AM57x processor family, the highest performance devices in this processor platform. Sitara AM57x processors are designed for a broad range of embedded and industrial applications through their unique heterogeneous architecture including ARM® Cortex®-A15 cores for high-performance processing and running a high-level operating system (HLOS). Additionally, AM57x processors integrate TI’s C66x digital signal processors (DSPs) for analytics and real-time computation, programmable real-time units (PRU) and ARM Cortex-M4 cores for control functions, and video and graphic accelerators for advanced user interfaces and multimedia applications, making the AM57x processors unmatched in their class.
The new Sitara AM57x family of processors was designed from the ground up with high performance and integration in mind. As a result, the processors bring developers unparalleled performance of more than 40 percent greater than quad-core ARM Cortex-A9 processors and 280 percent greater than standard dual-core ARM Cortex-A9 processors found in the broad embedded market.
To view the multimedia release go to:
http://www.multivu.com/players/English/70647530-ti-sitara-am57x-processor/
Global health service company Cigna today announced it is expanding access to its popular Coach by Cigna health and fitness mobile application to make it more broadly available to its clients and customers. Coach is now available on both Apple® iOS and Android™ mobile smart devices.
Currently a go-to health and fitness app for more than 350,000 users in 15 nations in nine languages, Coach by Cigna is now available at no charge in the App Store ℠ and Google Play™ stores for mobile devices that have either the Apple® iOS9 or the Android™ Lollipop operating system.
To view the multimedia release go to:
http://www.multivu.com/players/English/7448831-coach-by-cigna-fitness-app/
Huawei today unveiled its 2015-2016 Digital inCloud Program which aims to connect global carriers and partners to build up a digital ecosystem. Launched at the 2015 Innovation & Transformation Summit, the solution will facilitate: ease of distribution and trade between consumer, carriers, and partners of digital products/services. This facilitation will be achieved through improved content aggregation, better management of local and global digital content.
To view the multimedia release go to:
http://www.multivu.com/players/English/7671651-huawei-launch-digital-incloud-program/
The Egyptian Ministry of Antiquities is pleased to announce the launch of an egyptian – international Project using non-invasive and non-destructive surveying techniques for the scanning of Egyptian Pyramids under the title “ScanPyramids” project.
Just because a mystery is 4500 years old doesn’t mean it can’t be solved…” This could be the motto of the exceptional scientific mission launched October 25, 2015, under the authority of the Egyptian Ministry of Antiquities, initiated, designed and coordinated by the Faculty of Engineering of Cairo and the French HIP.Institute (Heritage, Innovation and Preservation). Radiographic muons, aka cosmic particles, infrared thermography, photogrammetry, scanner and 3D reconstruction: the most innovative technologies will be used by researchers of international renown and three major universities: the Faculty of Engineering of Cairo University, Université Laval of Quebec and Nagoya University of Japan. Their goal: to probe the heart of the largest pyramids of Egypt, without drilling the slightest opening.
Four millennia after their construction, these ancient giants are far from having yielded their secrets. The first mystery concerns their construction, especially Khufu, the last of the Seven Wonders of the Ancient World still existing: it is still impossible to describe with certainty how this stone monument, the largest ever built by humans, was erected.
The “ScanPyramids” project has already been approved by the permanent committee of the Ministry of Antiquities and has obtained all necessary permissions from concerned authorities. With a base of more than 5 hectares, its original height of almost 150 meters and a mass of 5 million tons, how was it possible to construct such a wonder in only 25 years?
To view the multimedia release go to:
http://www.multivu.com/players/uk/7671551-scanpyramids-project-launch-egyptian/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The S90 marks a giant step forward for Volvo Cars. The Swedish car maker is better known for its SUVs and estates, but with the launch of the S90 Volvo is clearly intent on shaking up the premium sedan segment with its distinctive executive class sedan.
Equipped with a host of new technologies ranging from cutting edge safety to cloud-based apps and services, the S90 is further proof of the Swedish brand’s continuing transformation.
“With the launch of the XC90 we made a clear statement of intent. We are now clearly and firmly in the game. With $11 USD billion of investment over the past five years we have not only reimagined what Volvo Cars can be – we are now delivering on our promise of a resurgent and relevant Volvo Cars brand,” said Håkan Samuelsson, President & CEO, Volvo Car Group.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7702651-volvo-stakes-its-claim-with-the-S90/
Crystal Lagoons broke the record for the “World's Largest Crystalline Lagoon” with the completion of its latest project in Egypt.
Twelve Crystal Lagoons totaling 250 acres will be the centerpiece of the $5.5 billion dollar, 1,850-acre development in Citystars Sharm El Sheikh. The record-breaking lagoon is 30 acres of crystal-clear water surrounded by white sandy beaches - perfect for swimming, sailing, kayaking and more.
Citystars Sharm el Sheikh's crystal lagoon get its salt water supply from wells in the middle of the desert that are otherwise useless, allowing for a tropical crystalline lagoon in the desert. In addition, the salt water used in the crystal lagoon features higher levels of purity and will be used for reverse osmosis desalinization processes, lowering the costs of water treatment.
To view the multimedia release go to:
http://www.multivu.com/players/English/7689951-crystal-lagoons-guinness-world-record/
St. Jude Children’s Research Hospital® officials and guests today marked the opening of the St. Jude Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
Patients are now being treated at the center using precisely delivered, high-energy particles called protons to kill or shrink tumors while minimizing damage to healthy tissue and organs. For patients with brain tumors and certain other cancers, research suggests proton beam therapy may be more effective than conventional radiation at preventing the growth and spread of tumors while reducing the risk of treatment-related side effects.
To view the multimedia release go to:
http://www.multivu.com/players/English/7713451-st-jude-proton-therapy-opening/
Clayton, one of America's largest builders of manufactured and modular homes, is proud to announce that it is being featured on the new show “Breakneck Builds” to showcase some of its customized modular homes for the debut season.
The series features a total of six different Clayton Built™ homes throughout Season One. Clayton interviewed two of the six families after filming commenced to give a behind-the-scenes look at the homes and the families living in them. The exclusive interviews featured the families of Roger and Jamie Linn, of Tijeras, N.M., and John Broadbooks of Black Hawk, Colo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7413931-clayton-homes-avoid-refund-regret/
